« previous next »
Pages: [1]

Author Topic: (Lancet editorial) MS under the spotlight  (Read 29 times)

0 Members and 0 Guests are viewing this topic.

Offline agate

  • Administrator
  • *****
  • Posts: 9542
  • MS diagnosed 1980
  • Location: Pacific Northwest
(Lancet editorial) MS under the spotlight
« on: June 20, 2021, 07:30:09 am »

The Lancet Neurology (July 2021) contains this editorial, "Multiple sclerosis under the spotlight," discussing the third edition of the MSIF Atlas of MS and its disclosure of the great disparities in MS diagnosis and treatment worldwide:


https://www.thelancet.com/journals/laneur/article/PIIS1474-4422(21)00170-8/fulltext


It seems to be true that there are many people in the world who can't afford to have MS.
Report to moderator   Logged
MS Speaks--online for 17 years

SPMS, diagnosed 1980. Avonex 2001-2004. Copaxone 2007-2010. Glatopa (glatiramer acetate 40mg 3 times/week) since 12/16/20.
Pages: [1]
« previous next »
 

Related Topics

  Subject / Started by Replies Last post
0 Replies
74 Views 		Last post September 22, 2017, 04:57:05 pm
by agate
0 Replies
93 Views 		Last post November 11, 2017, 09:36:06 am
by agate
1 Replies
135 Views 		Last post April 17, 2020, 07:58:36 am
by agate
0 Replies
10 Views 		Last post May 06, 2022, 10:40:34 am
by agate
1 Replies
9 Views 		Last post March 26, 2023, 09:16:05 pm
by agate